The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints

BCC marks the second non-melanoma skin cancer for which Libtayo has demonstrated first-in-class data, the firms note

The Billion Molecules against Covid19 Grand Challenge aims to screen billions of molecules with blocking interactions on SARS-CoV-2

The charity’s Centre for Drug Development will sponsor and fund a future Phase I clinical trial for CB213

The Day of Hand Hygiene takes place annually on 5 May. Originally initiated by the World Health Organization […]

Korean researchers have screened 48 FDA-approved drugs against SARS-CoV-2, and found that two, that are already FDA-approved for […]

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT

Updated Date: Mon, 27 Apr 2020 00:00:00 EDT